KEGG   DRUG: Tilatamig
Entry
D13066                      Drug                                   
Name
Tilatamig (USAN/INN)
Formula
C6401H9919N1715O2016S5
Exact mass
143229.4966
Mol weight
143314.84
Sequence
(A chain)
QVQLVQSGAE VKKPGSSVKV SCKASGGTFS DNDFSWVRQA PGQGLEWMGA IVAVFRTETY
AQKFQDRVKI TADISTRTTY MELSSLRSED TAVYYCARRL MSAISGPGAP LLMWGQGTLV
TVSSASTKGP SVCPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSVDKT HTCPPCPAPE
FEGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPASIE KTISKAKGQP REPQVYTLPP
CREEMTKNQV SLWCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGK
(B chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT DYYIHWVRQA TGQGLEWMGW MNPNSGNTGY
AQKFQGRVTM TRDTSISTAY MELSSLRSED TAVYYCARGQ GYTHSWGQGT MVTVSSASTK
GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA PEFEGGPSVF
LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
VVSVLTVLHQ DWLNGKEYKC KVSNKALPAS IEKTISKAKG QPREPQVCTL PPSREEMTKN
QVSLSCAVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLVSKLT VDKSRWQQGN
VFSCSVMHEA LHNHYTQKSL SLSPGK
(C chain)
QSALTQPRSV SGSPGQSVTI SCTGTSSDVG GYNYVSWYQQ HPGKAPKLMI YDVSKRPSGV
PDRFSGSKSG NTASLTISGL QAEDEADYYC SSYTSSDTLE IFGGGTKLTV LGQPKAAPSV
TLFPPCSEEL QANKATLVCL ISDFYPGAVT VAWKADSSPV KAGVETTTPS KQSNNKYAAS
SYLSLTPEQW KSHRSYSCQV THEGSTVEKT VAPTEVS
(D chain)
DIQMTQSPST LSASVGDRVT ITCRASEGIY HWLAWYQQKP GKAPKLLIYK ASSLASGVPS
RFSGSGSGTE FTLTISSLQP DDFATYYCQQ YSNYPPTFGG GTKLEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: A22-A96, A151-A207, A133-C126, A233-B225, A236-B228, A268-A328, A361-B348, A374-A432, B22-B96, B143-B199, B219-D214, B260-B320, B366-B424, C22-C90, C139-C198, D23-D88, D134-D194)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Bispecific antibody
Target
MET [HSA:4233] [KO:K05099]
EGFR [HSA:1956] [KO:K04361]
  Pathway
hsa04010  MAPK signaling pathway
hsa04014  Ras signaling pathway
hsa04015  Rap1 signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   EGFR family
    EGFR
     D13066  Tilatamig (USAN/INN)
   MET family
    MET
     D13066  Tilatamig (USAN/INN)
Other DBs
CAS: 2868265-50-1
PubChem: 505917339
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system